Figure 3. Pyroptosis phenotypes with different immune landscapes in the gastric cancer meta-cohort. (A) The relative abundance of 28 immune cells in the TME among distinct pyroptosis phenotypes through ssGSEA. (B) The mRNA expression of the main immune checkpoints among three pyroptosis phenotypes. The asterisks indicated the statistical p-values (*p < 0.05; **p < 0.01; ***p < 0.001). (C–E) The stromal score, tumor purity and immune score in three pyroptosis phenotypes.